5 reports

  • Ono Pharmaceutical Co., Ltd.: Research & Development
  • ONO PHARMACEUTICAL CO., LTD.: PARTNERSHIP

Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ono Pharmaceutical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

  • Pharmaceutical
  • Therapy
  • Japan
  • Company
  • Ono Pharmaceutical Co., Ltd.
  • Ono Pharmaceutical Co Ltd, Key Employees
  • Ono Pharmaceutical Co Ltd - Key Competitors

Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents.Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive...

  • Pharmaceutical
  • Japan
  • Company
  • Deals & Alliance
  • Ono Pharmaceutical Co., Ltd.
  • Ono Pharmaceutical Co. partnership volume and value trend (2014-YTD2018)
  • Ono Pharmaceutical Co. partnership trend by key deal type (2014-YTD2018)

Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Ono Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Ono Pharmaceutical Co., Ltd.
  • Ono Pharmaceutical Co. partnership trend by key deal type (2014-YTD2018)
  • Ono Pharmaceutical Co. partnership volume and value trend (2014-YTD2018)

Ono Pharmaceutical Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Ono Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Ono Pharmaceutical Co., Ltd.

Melanoma

4546 5000 3864
  • Opdivo late-phase clinical trial data in melanoma

Opdivo became the first PD-## inhibitor to reach the market when it was approved for the treatment of melanoma in Japan in July 2014 (Ono Pharmaceutical press release, 2014a).

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Company
  • Ono Pharmaceutical Co., Ltd.